Smith & Nephew plc (NYSE:SNN) Shares Purchased by BKM Wealth Management LLC

BKM Wealth Management LLC increased its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 17.8% during the first quarter, HoldingsChannel reports. The fund owned 18,240 shares of the medical equipment provider’s stock after buying an additional 2,757 shares during the period. BKM Wealth Management LLC’s holdings in Smith & Nephew were worth $463,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Scharf Investments LLC boosted its position in Smith & Nephew by 0.5% during the first quarter. Scharf Investments LLC now owns 2,996,264 shares of the medical equipment provider’s stock worth $75,985,000 after purchasing an additional 15,930 shares in the last quarter. American Century Companies Inc. boosted its position in Smith & Nephew by 343.5% during the third quarter. American Century Companies Inc. now owns 2,364,037 shares of the medical equipment provider’s stock worth $58,557,000 after purchasing an additional 1,830,965 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Smith & Nephew by 3.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,343,712 shares of the medical equipment provider’s stock worth $36,656,000 after purchasing an additional 44,445 shares in the last quarter. Brandes Investment Partners LP purchased a new stake in Smith & Nephew during the fourth quarter worth $29,884,000. Finally, Wells Fargo & Company MN boosted its position in Smith & Nephew by 20.9% during the fourth quarter. Wells Fargo & Company MN now owns 1,003,050 shares of the medical equipment provider’s stock worth $27,363,000 after purchasing an additional 173,448 shares in the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Stock Down 1.1 %

Shares of NYSE:SNN opened at $24.51 on Tuesday. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. Smith & Nephew plc has a 52-week low of $21.52 and a 52-week high of $31.31. The stock’s fifty day simple moving average is $25.17 and its 200-day simple moving average is $26.26. The company has a market capitalization of $10.72 billion, a P/E ratio of 11.96, a P/E/G ratio of 1.10 and a beta of 0.80.

Analyst Upgrades and Downgrades

SNN has been the topic of a number of research analyst reports. StockNews.com downgraded Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 13th. UBS Group upgraded Smith & Nephew from a “neutral” rating to a “buy” rating in a research report on Wednesday, June 5th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.